×
Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort PDF
$ 40.00
Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort PDF quantity
$ 40.00
×
Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia PDF
$ 40.00
Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia PDF quantity
$ 40.00
×
Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression PDF
$ 40.00
Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression PDF quantity
$ 40.00
×
A Prospective, Open-Label, Flexible-Dose Study of Quetiapine in the Treatment of Delirium PDF
$ 40.00
A Prospective, Open-Label, Flexible-Dose Study of Quetiapine in the Treatment of Delirium PDF quantity
$ 40.00
×
Remission Rates Following Antidepressant Therapy With Bupropion or Selective Serotonin Reuptake Inhibitors: A Meta-Analysis of Original Data From 7 Randomized Controlled Trials PDF
$ 40.00
Remission Rates Following Antidepressant Therapy With Bupropion or Selective Serotonin Reuptake Inhibitors: A Meta-Analysis of Original Data From 7 Randomized Controlled Trials PDF quantity
$ 40.00
×
A Naturalistic Study of Risperidone Treatment Outcome Using Prognosis-Adjusted Discharge Rates in New York State Inpatients PDF
$ 40.00
A Naturalistic Study of Risperidone Treatment Outcome Using Prognosis-Adjusted Discharge Rates in New York State Inpatients PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart